Loading
NASDAQBasic MaterialsChemicals - Specialty
Latest quote
$171.61
−$0.13 · -0.08%
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
Previous close
$171.61
−$0.13 · -0.08%
Regular session · ET · Market data may be delayed.
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
Day range
Current $171.61
52-week range
Current $171.61
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
55
Fair Value
Sentiment
51
Mixed
Risk
22
Moderate Risk
Momentum
46
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
Day range
Current $171.61
52-week range
Current $171.61
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.04B USD | 953.68M USD | 922.44M USD | 942.36M USD | 799.02M USD |
| Cost of goods sold | 666.53M USD | 617.48M USD | 620.38M USD | 661.91M USD | 555.85M USD |
| Gross profit | 370.63M USD | 336.21M USD | 302.06M USD | 280.45M USD | 243.17M USD |
| Research and development | 18.51M USD | 16.79M USD | 15.05M USD | 12.19M USD | 13.52M USD |
| Selling, general, and administrative | 142.8M USD | 136.5M USD | 130.13M USD | 123.07M USD | 102.15M USD |
| Operating expenses | 152.3M USD | 153.3M USD | 142.86M USD | 135.27M USD | 115.67M USD |
| Interest expense | 10.22M USD | 16.53M USD | 22.61M USD | 10.27M USD | 2.46M USD |
| Depreciation and amortization | 45.19M USD | 47.97M USD | 54.94M USD | 51.85M USD | 48.88M USD |
| Operating income | 218.33M USD | 182.91M USD | 159.19M USD | 145.19M USD | 127.5M USD |
| Net income | 154.85M USD | 128.48M USD | 108.54M USD | 105.37M USD | 96.1M USD |
Company facts updated Sep 8, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$215
25.28% upside| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Jan 21, 2010 | 3:2 | — | — |
Stock split | Jan 22, 2007 | 3:2 | — | — |
Stock split | Jan 23, 2006 | 3:2 | — | — |
Stock split | Jan 21, 2005 | 3:2 | — | — |
Stock split | Jun 4, 1998 | 3:2 | — | — |
Stock split | Oct 4, 1994 | 3:2 | — | — |
Effective Jan 21, 2010
3:2
Effective Jan 22, 2007
3:2
Effective Jan 23, 2006
3:2
Effective Jan 21, 2005
3:2
Effective Jun 4, 1998
3:2
Effective Oct 4, 1994
3:2
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core S&P Small-Cap ETFIJR348.87M0.31%109.96B USD0.06%$145.34+0.37%
Vanguard Morningstar Total Stock Market ETFVTI171.22M0.01%2.3T USD0.03%$379.73-0.32%
iShares Russell 2000 ETFIWM143.59M0.18%80.51B USD0.19%$296.01+0.28%
Vanguard Morningstar Small-Cap ETFVB123.8M0.07%183.4B USD0.03%$300.01+0.05%
First Trust SMID Cap Rising Dividend Achievers ETFSDVY98.64M0.85%11.56B USD0.58%$43.43-0.09%
Vanguard Morningstar Small-Cap Growth ETFVBK71.47M0.16%43.8B USD0.05%$349.44+0.01%
Vanguard Extended Market ETFVXF62.02M0.06%93.7B USD0.05%$242.66+0.14%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM50.62M0.31%16.52B USD0.03%$56.51+0.37%iShares Core S&P Small-Cap ETFIJRVanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Morningstar Small-Cap ETFVBFirst Trust SMID Cap Rising Dividend Achievers ETFSDVYVanguard Morningstar Small-Cap Growth ETFVBKVanguard Extended Market ETFVXFState Street SPDR Portfolio S&P 600 Small Cap ETFSPSMAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
